Breas Medical AB has completed the acquisition of B&D Electromedical Ltd. B&D serves the United Kingdom market for medical ventilators and airway clearance devices. Founded in 1987, B&D manufacturers the NIPPY brand.

B&D’s founders will remain with the company post-close to continue delivering customer service and to develop new, innovative NIPPY respiratory devices and airway clearance products for the UK and global markets. “Breas and B&D are a great fit and we look forward to working with the Breas team to build on the strong NIPPY brand that we helped create,” says Peter Bachelor, B&D co-founder, in a release.

Nicke Svanvik, Breas Medical president and CEO, says, “We have known and respected B&D for many years. Our two companies started at nearly the same time and each grew thanks to customer focused innovation, quality products, passion for our customers and patients, as well as an entrepreneurial spirit. We will continue to grow as a combined business under those same core values. Furthermore, our Breas customers in the UK can now benefit from our expanded capabilities and B&D’s excellent customer support and service.”

Paul Manning, CEO of Breas Medical parent company PBM Capital, says, “The B&D acquisition solidifies our market leadership in Europe and is another step in our strategy to be a meaningful global player in the respiratory medical device market. We will continue to pursue organic and inorganic growth opportunities to achieve our goals.”

In addition to ventilators, Breas, and now B&D, will market a line of sleep apnea devices including the Z1 CPAP. The Z1 CPAP device is now available in the United States, Europe, Canada, New Zealand, South Africa, India, Chile, Malaysia, and Hong Kong.